Metallothionein Gene Transfection Reverses the Phenotype of Activated Human Hepatic Stellate Cells
Authors:
- 1 July 2013
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 346 (1) , 48-53
Abstract
Metallothionein (MT) gene therapy leads to resolution of liver fibrosis in mouse model. The present study was undertaken to test the hypothesis that reversal of the phenotype of activated hepatic stellate cells (HSCs) contributes to the fibrinolysis effect of MT. Human HSC LX-2 cells were activated after they were cultured for 24 hours, as indicated by expression of α -smooth muscle actin ( α -SMA) and collagen-I and depressed expression of collagenases. Transfection with a plasmid containing human MT-IIA gene in the activated HSCs effectively increased the protein level of MT. The expression of MT was accompanied by the reduction in protein levels of α -SMA and collagen-I and a decrease in their mRNA levels. Of importance, MT gene transfection resulted in upregulation of matrix metalloproteinases 1, 8, and 13, which are involved in the resolution of liver fibrosis. This study demonstrates that reversal of the phenotype of activated HSCs, particularly the upregulation of collagenases, is likely to be involved in the resolution of liver fibrosis observed in MT gene therapy.Keywords
This publication has 33 references indexed in Scilit:
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Metallothionein and Liver Cell RegenerationExperimental Biology and Medicine, 2006
- Metallothionein Disulfides Are Present in Metallothionein-overexpressing Transgenic Mouse Heart and Increase under Conditions of Oxidative StressJournal of Biological Chemistry, 2006
- Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse heartsBiochemical and Biophysical Research Communications, 2005
- Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the ratGastroenterology, 2003
- Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversionGene Therapy, 2002
- Extracellular Matrix Degradation and the Role of Hepatic Stellate CellsSeminars in Liver Disease, 2001
- Leptin Augments Inflammatory and Profibrogenic Responses in the Murine Liver Induced by Hepatotoxic ChemicalsHepatology, 2001
- Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell modelFEBS Letters, 2001
- The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patientsJournal of Hepatology, 1998